Seattle, WA, United States of America

Roger T Coleman

This inventor holds 36 USPTO granted patents, primarily in Chemokine Antibodies. Top assignees: Incyte Pharmaceuticals, Inc., Incyte Corporation, Incyte Genomics, Inc.. Active years: 1997-2015.


% Patents Active = 88.9

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 115(Granted Patents)


Location History:

  • Palo Alto, CA (US) (1999)
  • Mountain View, CA (US) (1997 - 2007)
  • Seattle, WA (US) (2008 - 2015)

Company Filing History:


Years Active: 1997-2015

Loading Chart...
Areas of Expertise:
Chemokine PANEC-1
Chemokine PANEC-2
JAK2 Kinase
Cathepsin Proteins
Monocyte Activating Cytokine
Purinergic Receptor
Thrombin Receptor
Cyclic Nucleotide Phosphodiesterase
Polynucleotides
Antibodies
Human Proteins
Pancreatic Cancer
36 patents (USPTO):Explore Patents

Title: Roger T Coleman - Innovative Inventor from Seattle

Introduction: Roger T Coleman is a renowned inventor based in Seattle, WA, known for his groundbreaking contributions to various industries.

Latest Patents: Roger T Coleman holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the innovation sector, Roger T Coleman has led numerous successful projects from concept to execution, revolutionizing the way we approach modern challenges.

Collaborations: Throughout his career, Roger T Coleman has collaborated with leading companies, research institutions, and universities, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Roger T Coleman's passion for innovation and his relentless drive to push boundaries make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…